SC7: PROTEIN AGGREGATION: MECHANISM, CHARACTERIZATION AND CONSEQUENCES

TUESDAY, AUGUST 13 | 6:00 – 8:30 PM | DINNER PROVIDED

Cambridge

ABOUT THIS COURSE:

Protein aggregation is recognized by regulatory agencies and the biopharmaceutical industry as a key quality attribute of biotherapeutics. Various aggregates hold the potential for adversely impacting production and patients in a variety of ways. This in-depth course reviews the origins and consequences of aggregation in biotherapeutics, and then examines strategies for predicting and quantifying aggregation in biopharmaceuticals. It benefits scientists engaged in the development, production, analytical characterization and approval of biotherapeutics and who require a good working knowledge of protein aggregation.

WHAT YOU WILL LEARN:

• Which phenomena are described by the term “protein aggregation”?
• How does a protein aggregate form, and what factors influence their formation?
• What are the mechanisms of protein aggregations?
• How do aggregate size, morphology and surface chemistry determine immunogenicity?
• How can protein aggregation be predicted?
• What changes may be made to the protein and solvent to minimize aggregation?
• What are the key analytical challenges in characterizing protein aggregates?
• Analytical tools for prediction and quantification of protein aggregates

INSTRUCTOR BIOGRAPHIES:

Thomas Laue, PhD, Professor Emeritus, Molecular, Cellular and Biomedical Sciences, University of New Hampshire

Tom Laue is the Carpenter Professor of Molecular, Cellular and Biomedical Sciences, and professor of Material Sciences at the University of New Hampshire. He is the Director of both the Center to Advance Molecular Interaction Science and the Biomolecular Interaction Technologies Center. He received his bachelor’s degree in Natural Sciences from the Johns Hopkins University in 1971 and his PhD in Biophysics and Biochemistry from the University of Connecticut in 1981. His post-doctoral studies were conducted at the University of Oklahoma. Between 1969 and 1975, he worked as a technician in the deep space program of NASA. He joined the University of New Hampshire in 1984 as an Assistant Professor, and teaches both undergraduate and graduate courses in biochemistry and biophysics. His research focuses on the development of instrumentation and methods that use the fundamental properties of mass and charge for examining macromolecular interactions. These instruments provide unique insights into these interactions, and have resulted in extensive collaborations with both academic and industrial labs. Tom has over 120 publications, serves on several editorial boards, and gives over one hundred lectures, seminars and workshops a year.

Matthew Brown PhD, Applications Manager, Bioscience, Malvern PANalytical

Matt Brown completed his PhD at the University of London and followed this with Postdoctoral Fellowships at Harvard Medical School, in Boston, USA. Prior to joining Malvern Panalytical, Matt worked in the biopharmaceutical sector, employing a range of biophysical and biochemical methods to support bioprocess development and commercial manufacturing operations. Currently, Matt is the Bioscience Applications Manager for the US, specializing in the Biopharmaceutical sector.